Chemerin serum levels in girls with anorexia nervosa

Neuroendocrinology Letters

Volumn 35, Issue 6, 2014, Pages 490-496

  Os̈więcimska, Joanna ^a   Ziora, Katarzyna ^a   Suwała, Andrzej ^b   Świętochowska, Elzbieta ^a   Gorczyca, Piotr ^a   Ziora Jakutowicz, Karolina ^c   Machura, Edyta ^a   Szczepańska, Maria ^a   Ostrowska, Zofia ^a   Ziora, Dariusz ^a   Szalecki, Mieczysław ^d,e   Stojewska, Małgorzata ^a   Matusik, Paweł ^a   Małecka Tendera, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Anmedis   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

Adolescents; Anorexia nervosa; Chemerin; Eating disorders; Obesity

Indexed keywords

CHEMERIN; INSULIN; CHEMERIN, HUMAN; CHEMOKINE;

ANOREXIA NERVOSA; ARTICLE; BODY MASS; CHILDHOOD OBESITY; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POLISH CITIZEN; PROTEIN BLOOD LEVEL; ADIPOGENESIS; ADOLESCENT; BLOOD; BODY WEIGHT; CHILD; COMPARATIVE STUDY; ENERGY METABOLISM; NUTRITIONAL STATUS; OBESITY; PHYSIOLOGY;

ADIPOGENESIS; ADOLESCENT; ANOREXIA NERVOSA; BODY MASS INDEX; BODY WEIGHT; CHEMOKINES; CHILD; ENERGY METABOLISM; FEMALE; HUMANS; NUTRITIONAL STATUS; OBESITY;

EID: 84922533986     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC: APA.
2. Bauer S, Wanninger J, Schmidhofer S, Weigert J, Neumeier M, Dorn C, et al. (2011). Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology. 152:26-35.
3. Becker M, Rabe K, Lebherz C Zugwurst J, Göke B, Parhofer KG, et al. (2010). Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on hight-fat diet. Diabetes. 59:2898-2903.
4. Bozaglou K, Bolton K, McMillan J Zimmet P, Jowett J, Collier G, et al. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 148:4687-4694.
5. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, et al. (2009). Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab. 94:3085-3088.
6. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, et al. (2010). Chemerin a novel adipokine in the regulation of angiogenesis. Clin Endocrinol Metab. 95:2476-2485.
7. Brunetti L, Di Nisio C, Recinella L Chiavaroli A, Leone S, Ferrante C, et al. (2011). Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides. 32:1866-1871.
8. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, et al. (2008). Synthetic chemerin-derived peptides suppress inflammation through Chem 23. J Exp Med. 205:767-775.
9. Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, et al. (2013). Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-a stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis. 9:306-314.
10. Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, et al. (2012). Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism. 61:706-714.
11. Czekalski S, Krzyżanowska-͆winiarska B, Lewiński A, Milewicz A, Hilczer M, Pniewska-Siark B, et al. (2001). Narodowy Program Zapobiegania i Leczenia Otyłos̈ci. Program do realizacji w latach 2001-2005. Endokrynol Pol. 52(Suppl 1 do z.3):86-119.
12. Ernst MC, Issa M, Goralski KB, Sinai CJ (2010). Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology. 151:1998-2007.
13. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. (2007). Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biochem. 282:28175-28188.
14. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, et al. (2009). Interleukin-1 β induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept. 154:102-106.
15. Muruganandan S, Roman AA, Sinai CJ (2010). Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res. 25:222-234.
16. Muruganandan S, Parlee SD, Rourke JL Ernst MC, Goralski KB, Sinai CJ (2011). Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 286:23982-23995.
17. Nagpal S, Patel S., Jacobe H, Di Sepio D, Ghosn C, Malhotra M, et al. (1997). Tazarotene-induced gene 2(TIG2), a novel retinoid responsive gene skin. J Invest Dermat. 109:91-95.
18. Nogal P, Lewiński A (2008). Jadłowstręt psychiczny. Endokrynol Pol. 59:148-155.
19. Palczewska I, Niedźwiecka Z (2001). Somatic development indices in children and youth of Warsaw. Med Wieku Rozwoj. 2(Suppl 1):108-118.
20. Ress C, Tshoner A, Engl J, Klaus A, Tilg H, Ebenbichler CF, et al. (2010). Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest. 40:277-280.
21. Rhee E-J. (2011). Chemerin: a novel link between inflammation and atherosclerosis. Diabetes Met J. 35:216-218.
22. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, et al. (2007). Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 362:1013-1018.
23. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. (2009). Chemerin is novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 58:2731-2740.
24. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, et al. (2010). Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 95:2892-2896.
25. Shin HY, Lee DC, Chu SH, Jeon JY, Lee MK, Im JA, et al. (2001). Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin Endocrinol. (Oxf). 77:47-50.
26. Shin HY, Lee DC, Chu SH, Jeon JY, Lee MK, Im A, et al. (2012). Lee JW Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin Endocrinol (Oxf). 77:47-50.
27. Stejksal D, Karpisek M, Hanulova Z, Svestak M (2008). Chemerin is an independent marker of the metabolic syndrome in a Caucasian population - a pilot study. Biomed Pap Med Fac Univ Palacky Olomunc Czech Repub. 152:217-224.
28. Takahashi M, Takahashi Y, Takaghashi K, Zolotaryov FN, Hong KS, Kitazawa R, et al. (2008). Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582:573-578.
29. Tönjes A, Fasshauer M, Kratzsch J, Stumvoll M, Blüher M (2010). Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One. 5:1-6.
30. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. (2003) Specific recruitment of antigen-present-ing cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 198:977-985.
31. Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M, Communi D (2005). Neutrophil-mediated maturation of chemerin: a link between innate and adaptative immunity. J Immunol. 175:487-493.
32. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM, et al. (2005). Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem. 280:34661-34666.
33. Ziora K, Os̈więcimska J, ͆więtochowska E, Stojewska M, Ostrowska Z, Suwała A, et al. (2010). Ocena stężeń leptyny-hormonu tkanki tłuszczowej w surowicy krwi u dziewcząt z jadłowstrętem psychicznym. Endokrynol. Pediatr. 9:43-53.
34. Ziora K, Os̈więcimska J, ͆więtochowska E, Ziora D, Ostrowska Z, Stojewska M, et al. (2010). Assessment of serum apelin levels in girls with anorexia nervosa. J Clin Endocrinol Metab. 95:2935-2941.
35. Ziora K, Os̈więcimska J, ͆więtochowska E, Stojewska M, Ostrowska Z, Suwała A, et al. (2010). Ocena stężeń adiponektyny - hormonu tkanki tłuszczowej w surowicy krwi u dziewcząt z jadłowstrętem psychicznym. Endokrynol. Pediatr. 9:31-41.
36. Ziora KT, Oswiecimska JM, ͆więtochowska E, Ostrowska Z, Stojewska M, Gorczyca P, et al. (2012). Assessment of serum levels resistin in girls with anorexia nervosa. Part I. Relationship between resistin and body mass index. Neuroendocrinol Lett. 32:691-696.
37. Ziora K, Os̈więcimska J, ͆więtochowska E, Ziora D, Stojewska M, Suwała A, et al. (2012). Assessment of serum visfatin levels in girls with anorexia nervosa. Clin Endocrinol. 76:514-519.